Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U8OK
|
||||
Former ID |
DIB018334
|
||||
Drug Name |
[3H]mesulergine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539466] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H27N3O2S
|
||||
InChI |
InChI=1S/C19H27N3O2S/c1-20(2)25(23,24)12-13-8-16-15-6-5-7-17-19(15)14(11-22(17)4)9-18(16)21(3)10-13/h5-7,11,13,16,18H,8-10,12H2,1-4H3
|
||||
InChIKey |
WYCMFCPHWDZHMR-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2C receptor | Target Info | Antagonist | [525477] | |
5-hydroxytryptamine 2B receptor | Target Info | Antagonist | [527178] | ||
References | |||||
Ref 525477 | High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action. J Neurochem. 1999 May;72(5):2127-34. | ||||
Ref 527178 | Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn Schmiedebergs Arch Pharmacol. 2004 Aug;370(2):114-23. Epub 2004 Jul 30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.